European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Pier Luigi Zinzani; Lionel Karlin; John Radford; Dolores Caballero; Paul Fields; Martine E. D. Chamuleau; Francesco d'Amore; Corinne Haioun; Catherine Thieblemont; Eva Gonzalez-Barca; Carlos Grande Garcia; Peter W. Johnson; Gustaaf W. van Imhoff; Thomas Ng; Karen Dwyer; Franck Morschhauser

doi:10.3324/haematol.2016.146977

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Pier Luigi Zinzani^*, Lionel Karlin, John Radford, Dolores Caballero, Paul Fields, Martine E. D. Chamuleau, Francesco d'Amore, Corinne Haioun, Catherine Thieblemont, Eva Gonzalez-Barca, Carlos Grande Garcia, Peter W. Johnson, Gustaaf W. van Imhoff, Thomas Ng, Karen Dwyer, Franck Morschhauser

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

41 Citaten (Scopus)

215 Downloads (Pure)

Originele taal-2	English
Artikelnummer	407
Pagina's (van-tot)	E407-E410
Aantal pagina's	4
Tijdschrift	Haematologica
Volume	101
Nummer van het tijdschrift	10
DOI's	https://doi.org/10.3324/haematol.2016.146977
Status	Published - okt.-2016

Toegang tot document

10.3324/haematol.2016.146977Licentie: Unspecified

European Phase II Study Of Mogamulizumab, An Anti-CCR4 Monoclonal Antibody, In Relapsed/Refractory Peripheral T-Cell LymphomaFinal publisher's version, 558 KBLicentie: Unspecified

Handle.net

Permanente koppeling

Citeer dit

Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D., d'Amore, F., Haioun, C., Thieblemont, C., Gonzalez-Barca, E., Grande Garcia, C., Johnson, P. W., van Imhoff, G. W., Ng, T., Dwyer, K., & Morschhauser, F. (2016). European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica, 101(10), E407-E410. Artikel 407. https://doi.org/10.3324/haematol.2016.146977

@article{5155764cf1514c7b9a7b7a68ff9f69c7,

title = "European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma",

keywords = "aggressive non-Hodgkin lymphoma, mogamulizumab, anti-CCR4 monoclonal antibody, peripheral T-cell lymphoma",

author = "Zinzani, {Pier Luigi} and Lionel Karlin and John Radford and Dolores Caballero and Paul Fields and Chamuleau, {Martine E. D.} and Francesco d'Amore and Corinne Haioun and Catherine Thieblemont and Eva Gonzalez-Barca and {Grande Garcia}, Carlos and Johnson, {Peter W.} and {van Imhoff}, {Gustaaf W.} and Thomas Ng and Karen Dwyer and Franck Morschhauser",

year = "2016",

month = oct,

doi = "10.3324/haematol.2016.146977",

language = "English",

volume = "101",

pages = "E407--E410",

journal = "Haematologica",

issn = "0390-6078",

publisher = "FERRATA STORTI FOUNDATION",

number = "10",

}

Zinzani, PL, Karlin, L, Radford, J, Caballero, D, Fields, P, Chamuleau, MED, d'Amore, F, Haioun, C, Thieblemont, C, Gonzalez-Barca, E, Grande Garcia, C, Johnson, PW, van Imhoff, GW, Ng, T, Dwyer, K & Morschhauser, F 2016, 'European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma', Haematologica, vol. 101, nr. 10, 407, blz. E407-E410. https://doi.org/10.3324/haematol.2016.146977

TY - JOUR

T1 - European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

AU - Zinzani, Pier Luigi

AU - Karlin, Lionel

AU - Radford, John

AU - Caballero, Dolores

AU - Fields, Paul

AU - Chamuleau, Martine E. D.

AU - d'Amore, Francesco

AU - Haioun, Corinne

AU - Thieblemont, Catherine

AU - Gonzalez-Barca, Eva

AU - Grande Garcia, Carlos

AU - Johnson, Peter W.

AU - van Imhoff, Gustaaf W.

AU - Ng, Thomas

AU - Dwyer, Karen

AU - Morschhauser, Franck

PY - 2016/10

Y1 - 2016/10

KW - aggressive non-Hodgkin lymphoma

KW - mogamulizumab

KW - anti-CCR4 monoclonal antibody

KW - peripheral T-cell lymphoma

U2 - 10.3324/haematol.2016.146977

DO - 10.3324/haematol.2016.146977

M3 - Comment/Letter to the editor

C2 - 27418646

SN - 0390-6078

VL - 101

SP - E407-E410

JO - Haematologica

JF - Haematologica

IS - 10

M1 - 407

ER -